Sort
50,496 grants matching “lung cancer”
Improving Risk Factors for Diabetes Complications in Primary Care
$509,490Michael L Parchman · University Of Texas Hlth Science Center · R18 · FY2010 · DK
Care coordination for complex cancer survivors in an integrated safety-net system
$509,440Simon J. Craddock Lee · Ut Southwestern Medical Center · R01 · FY2017 · CA
Varicella virus antigens in glioma etiology and survival
$509,396Joseph Leo Wiemels · University Of California, San Francisco · U01 · FY2016 · CA
RNDI- Mediated Breast Cancer Suppression
$509,318Filippo G Giancotti · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$509,276Stephen S Hecht · University Of Minnesota · R01 · FY2016 · CA
HTS for TGF-beta receptor assembly inhibitors with anti-tumor and anti-fibrosis activities
$509,271Andrew P Hinck · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Targeting Early Drivers of Prostate Cancer Lineage Plasticity
$509,246Joshi James Alumkal · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Imaging the multifaceted response to a bispecific antibody therapy
$509,226Bernadette Marquez-Nostra · Yale University · R01 · FY2021 · CA
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
$509,200Jennifer Joy Smith · Precyte, Inc. · R44 · FY2019 · CA
Cell Sorter Grant for ECU Flow Cytometry Core Facility
$509,108Kymberly Mae Gowdy · East Carolina University · S10 · FY2016 · OD
Role of PI3Kgamma in Tumor Progression and Metastasis
$509,078Judith A. Varner · University Of California, San Diego · R01 · FY2024 · CA
Descriptive Studies and Record Linkage
$509,014Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Novel DNA damage response therapeutics targeting replication protein A
$509,008John J Turchi · Indiana University Indianapolis · R01 · FY2021 · CA
Role of ACER2 in cancer chemoresistance and metastasis
$509,005Cungui Mao · State University New York Stony Brook · R01 · FY2025 · CA
Engineered Monothiol Thioredoxin for Treatment of Radiation Induced Lung Injury
$508,988Peter B Heifetz · Orpro Therapeutics, Inc. · R41 · FY2025 · HL
RNDI- Mediated Breast Cancer Suppression
$508,979Filippo G Giancotti · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Hermansky Pudlak Syndrome & melanosome formation
$508,897Michael S Marks · University Of Pennsylvania · R01 · FY2010 · EY
Pancreatic cancer-associated fibroblasts: function, detection, and regulation
$508,889Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA
Dissemination and implementation of a corrective intervention to improve mediasti
$508,872Raymond U Osarogiagbon · University Of Memphis · R01 · FY2016 · CA
Developing Selective EphA2 Inhibitors for the treatment of Cancer
$508,812Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Endothelial Dysfunction in Radiation-induced Lung and Heart Toxicity
$508,784Ross B Mikkelsen · Virginia Commonwealth University · U01 · FY2020 · AI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$508,739David B Shackelford · University Of California Los Angeles · R01 · FY2024 · CA
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
$508,694Namita Rout · Tulane University Of Louisiana · R33 · FY2020 · AI
Proteomic determinants of response to checkpoint blockade in malignant pleuralmesothelioma
$508,688Bryan Michael Burt · Baylor College Of Medicine · R37 · FY2022 · CA
Novel approach to attenuate small cell lung cancer growth and metastasis
$508,682Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2022 · CA